Hangzhou Diagens Biotechnology Co., Ltd.

Research Hangzhou Diagens Biotechnology Co., Ltd. (2526.HK) on Bullrun: market cap HKD 20.62B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 20.62B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 20.62Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Hangzhou Diagens Biotechnology Co., Ltd.

Hangzhou Diagens Biotechnology Co., Ltd., a medical devices company, develops medical imaging products and services. It operates through Medical Imaging Software and Medical Devices, Technology Licensing, Analysis and Consulting Services, and Others segments. The company's products portfolio include AI AutoVision, a chromosome karyotype assisted diagnosis and analysis system that provides intelligent karyotyping analysis with applications across genetics and hematologic oncology;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223.SZ) Cofoe Medical Technology Co.,Ltd. (1187.HK) LifeTech Scientific Corporation (1302.HK) Star Sports Medicine Co., Ltd. (1609.HK) China Isotope & Radiation Corporation (1763.HK) AK Medical Holdings Limited (1789.HK) Suzhou Basecare Medical Corporation Limited (2170.HK) Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) Broncus Holding Corporation (2216.HK) MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) Rainmed Medical Limited (2297.HK) Yestar Healthcare Holdings Company Limited (2393.HK)

Frequently asked questions

What is Hangzhou Diagens Biotechnology Co., Ltd.'s market cap?

Hangzhou Diagens Biotechnology Co., Ltd.'s market capitalization is HKD 20.62B.

What does Hangzhou Diagens Biotechnology Co., Ltd. do?

Hangzhou Diagens Biotechnology Co., Ltd., a medical devices company, develops medical imaging products and services. It operates through Medical Imaging Software and Medical Devices, Technology Licensing, Analysis and Consulting Services, and Others segments.